Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of solid tumors

Published:2024-01-16 Issue:1 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ma Mina¹,Yao Liang²,Li Meixuan¹,Qin Yu¹,Yang Minyan¹,Guo Ke³,Duan Yanan⁴,Liu Bei⁵,Yang Kehu¹³

Affiliation:

1. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University; Lanzhou, Gansu China

2. Department of Health Research Methods, Evidence, and Impact; McMaster University; Hamilton Canada

3. Social Sciences Research Center, School of Public Health, Lanzhou University; Lanzhou, Gansu China

4. The School of Dental Medicine, Lanzhou University; Lanzhou, Gansu China

5. Department of Hematology; The First Hospital of Lanzhou University; Lanzhou, Gansu China

Publisher

Wiley

Reference82 articles.

1. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours;Aapro;European Journal of Cancer,2011

2. Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care, China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association;Ba;Cancer Biology & Medicine,2020

3. Molecular and functional imaging in cancer-targeted therapy: current applications and future directions;Bai;Signal Transduction and Targeted Therapy,2023

4. Chemoradiation and granulocyte-colony or granulocyte macrophage-colony stimulating factors: time to think out of the box?;Benna;British Journal of Radiology,2020

5. Chemotherapy-induced neutropenia and febrile neutropenia in the US: a beast of burden that needs to be tamed?;Boccia;Oncologist,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3